Norgestimate is a progestin medication that is used in birth control pills for women and in menopausal hormone therapy. The medication is available in combination with an estrogen and is not available alone. It is taken by mouth.

Sterling holds Certificate of Suitability n. R0-CEP 2009-305-Rev 00 issued by Quality of Medicines & HealthCare (EDQM) on 15/12/2011.

US DMF was submitted to FDA on 04/10/2001 and the following number was assigned n. 15649.

Drug product containing Sterling’s Norgestimate is commercialized in USA.